2023

Articles

Our brain shape influences how it works, landmark study finds

How brain activity resonates across and through its architecture could be more important than connections between neurons. The new research in Nature could mean studying the brain to understand its role in health is more straightforward.

AI drug discovery will power collaboration with Pharos Therapeutics

Partnership with Pharos will give the Drug Discovery Initiative access to the Pharos Chemiverse platform, with more than 230 million pieces of data to help identify promising compounds.

Professor Richard Payne elected Fellow of the Australian Academy of Science

In recognition of his international leadership in chemical biology and organic chemistry, Professor Payne from the School of Chemistry has joined the ranks of esteemed scientists as a Fellow in the Australian Academy of Science.

New technique substantially reduces mouse damage to crops even during plagues

A non-toxic method to prevent mice from devouring wheat crops has been shown to drastically reduce seed loss.

Iver Cairns recognised as Scientist of the Year at the Australian Space Awards

Winning from a group of 10 finalists, Professor Iver Cairns has dedicated his award to the scientists and students helping build Australia's space industry through CUAVA training centre.

Growing sustainable everyday products using mushrooms

Researchers from the University of Sydney have developed a biological growing process that uses mushrooms to turn organic waste into compostable products as a low-cost, sustainable solution to plastics.

Four ARC Early Career Industry Fellowships

Dr Nicky Wright and Dr Jianping Zhang, from the Faculty of Science, and Dr Eason (Yi-Sheng) Chen and Dr Rui Tang, from the Faculty of Engineering, have been successful in receiving ARC Early Career Industry Fellowships.

Guilt-free energy

A recent gift has accelerated hydrogren researcher Professor Kondo Francois Aguey-Zinsou towards his goal of producing zero-carbon energy for everyone.

Sydney spinout lands $273m deal to develop drugs for psychiatric disorders

Compounds developed by Professor Michael Kassiou's drug discovery team for Kinoxis Therapeutics will be used to target oxytocin receptors with the aim of creating medicine to treat schizophrenia, depression and other neuropsychiatric illness.

Innovation Hub opens first stage of the Sydney Biomedical Accelerator

First space to open at the Sydney Biomedical Accelerator will allow researchers, clinicians and industry partners to generate ideas, form new partnerships and accelerate innovation.

3 4 5 6 7 8 9 10 11 12